Objectives:

1. Better understand clinical outcomes related to deep brain stimulation in early stage Parkinson’s disease;
2. Better understand research fi ndings that suggest that deep brain stimulation in early stage Parkinson’s disease may be disease modifying; and
3. Better understand the design of an upcoming FDA approved pivotal trial of deep brain stimulation in early stage Parkinson’s disease.

 

Session date: 
Thursday, September 21, 2017 - 3:00pm to 4:00pm
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.